David M. Holtzman

发表

Faculty Opinions recommendation of Dynamics of retrieval strategies for remote memories.

David M. Holtzman, Adam W. Bero, D. Holtzman, 2012 .

YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease

Chengjie Xiong, John X. Morris, Ge Li, 2010, Biological Psychiatry.

Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease

Nick C. Fox, Reisa A. Sperling, Daniel S. Marcus, 2018, Neurology.

Increased in Vivo Amyloid-β42 Production, Exchange, and Loss in Presenilin Mutation Carriers

Tammie L. S. Benzinger, Rachel Potter, Tyler Blazey, 2013, Science Translational Medicine.

Biomarkers of Alzheimer's disease

David M. Holtzman, Anne M. Fagan, A. Fagan, 2009, Neurobiology of Disease.

Apolipoprotein E controls cerebrovascular integrity via cyclophilin A

Berislav V. Zlokovic, Itender Singh, Jan Sallstrom, 2012, Nature.

Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer’s Disease

Reisa A. Sperling, Martin N. Rossor, Chengjie Xiong, 2014, Science Translational Medicine.

Amyloid-β Dynamics Are Regulated by Orexin and the Sleep-Wake Cycle

Seiji Nishino, Miranda M. Lim, David M. Holtzman, 2009, Science.

Comparative Proteomic Analysis of Intra- and Interindividual Variation in Human Cerebrospinal Fluid*S

James P. Malone, David M. Holtzman, Anne M. Fagan, 2005, Molecular & Cellular Proteomics.

Novel allele-dependent role for APOE in controlling the rate of synapse pruning by astrocytes

Bradley T. Hyman, Ben A. Barres, David M. Holtzman, 2016, Proceedings of the National Academy of Sciences.

The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging and Alzheimer's Association workgroup

Nick C. Fox, Anthony Gamst, Nick C Fox, 2011 .

Glial Fibrillary Acidic Protein – Apolipoprotein E ( apoE ) Transgenic Mice : Astrocyte-Specific Expression and Differing Biological Effects of Astrocyte-Secreted apoE 3 and apoE 4 Lipoproteins

Guojun Bu, Yuling Sun, David M. Holtzman, 1998 .

Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease

Yi Su, Brian A. Gordon, Tammie L. S. Benzinger, 2016, Science Translational Medicine.

Altered sleep and EEG power in the P301S Tau transgenic mouse model

David M. Holtzman, D. Holtzman, Thomas E Mahan, 2017, Annals of clinical and translational neurology.

Neuronal activity regulates the regional vulnerability to amyloid-β deposition

Jee Hoon Roh, Jin-Moo Lee, Marcus E. Raichle, 2011, Nature Neuroscience.

Preclinical Alzheimer's disease and longitudinal driving decline

Chengjie Xiong, Brian R. Ott, Peggy P. Barco, 2016, Alzheimer's & dementia.

Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease

Murray Grossman, Chengjie Xiong, John X. Morris, 2012, Neurology.

Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease

David J. Cummins, David M. Holtzman, D. Holtzman, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Proteopathic tau seeding predicts tauopathy in vivo

Nigel J. Cairns, David M. Holtzman, D. Holtzman, 2014, Proceedings of the National Academy of Sciences.

A synthetic peptide blocking the apolipoprotein E/β-amyloid binding mitigates β-amyloid toxicity and fibril formation in vitro and reduces β-amyloid plaques in transgenic mice

Thomas Wisniewski, Paul M. Mathews, Stephen D. Schmidt, 2004 .

Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer disease: a longitudinal study

Andrew J. Saykin, Paul M. Thompson, Clifford R. Jack, 2018, The Lancet Neurology.

Genome-Wide Association Study of CSF Levels of 59 Alzheimer's Disease Candidate Proteins: Significant Associations with Proteins Involved in Amyloid Processing and Inflammation

Perry G. Ridge, Benjamin J. Ainscough, Oscar Harari, 2014, PLoS genetics.

Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease

Ge Li, Jeffrey A. Kaye, R. Reid Townsend, 2011, PloS one.

p140 trk mRNA marks NGF-responsive forebrain neurons: Evidence that trk gene expression is induced by NGF

Joseph B. Long, David M. Holtzman, D. Holtzman, 1992, Neuron.

Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums

Steven E. Arnold, Suzanne Craft, David M. Holtzman, 2018, Nature Reviews Neurology.

Progress Update: Fluid and Imaging Biomarkers in Alzheimer’s Disease

David M. Holtzman, Anne M. Fagan, A. Fagan, 2014, Biological Psychiatry.

Endocytosis Is Required for Synaptic Activity-Dependent Release of Amyloid-β In Vivo

Guojun Bu, Steven Mennerick, David M. Holtzman, 2008, Neuron.

Task-evoked fMRI changes in attention networks are associated with preclinical Alzheimer’s disease biomarkers

Jeffrey M. Zacks, David A. Balota, Brian A. Gordon, 2015, Neurobiology of Aging.

Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis

Chengjie Xiong, Max Kuhn, Jingxia Liu, 2011, PloS one.